Literature DB >> 11739821

Age at onset of narcolepsy in two large populations of patients in France and Quebec.

Y Dauvilliers1, J Montplaisir, N Molinari, B Carlander, B Ondze, A Besset, M Billiard.   

Abstract

BACKGROUND: Narcolepsy usually starts around adolescence; however, there is great variability in the clinical presentation of narcolepsy.
OBJECTIVE: To determine the age at onset in conjunction with severity of narcoleptic symptoms in two large populations of narcoleptic patients with a similar genetic background.
METHODS: Information on age at onset and severity of the condition was obtained in 317 patients with well-defined narcolepsy-cataplexy from Montpellier (France) and in 202 from Montreal (Canada).
RESULTS: The mean age at onset was 23.4 years in Montpellier and 24.4 in Montreal. The age at onset was bimodal in two independent patient populations: a first peak occurring at 14.7 years, and a second peak occurring at 35. Age at onset clearly differentiates patients with a positive family history of narcolepsy (early onset) from those without a family history. Other clinical and polygraphic findings may indicate that young age at onset is associated with increased severity of the condition (higher frequency of cataplexy and decreased mean sleep latency on the Multiple Sleep Latency Test).
CONCLUSION: Bimodal distribution of age at onset of narcolepsy was found in two independent patient populations. Our data suggest that age at onset is genetically determined.

Entities:  

Mesh:

Year:  2001        PMID: 11739821     DOI: 10.1212/wnl.57.11.2029

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  69 in total

1.  Post-H1N1 narcolepsy-cataplexy.

Authors:  Yves Dauvilliers; Jacques Montplaisir; Valéerie Cochen; Alex Desautels; Mali Einen; Ling Lin; Minae Kawashima; Sophie Bayard; Christelle Monaca; Michel Tiberge; Daniel Filipini; Asit Tripathy; Bich Hong Nguyen; Suresh Kotagal; Emmanuel Mignot
Journal:  Sleep       Date:  2010-11       Impact factor: 5.849

2.  Understanding Racial Differences in Narcolepsy Symptoms May Improve Diagnosis.

Authors:  Kiran Maski
Journal:  Sleep       Date:  2015-11-01       Impact factor: 5.849

Review 3.  Narcolepsy: immunological aspects.

Authors:  Sebastiaan Overeem; John Logan Black; Gert Jan Lammers
Journal:  Sleep Med Rev       Date:  2008-03-04       Impact factor: 11.609

Review 4.  The diagnosis and treatment of pediatric narcolepsy.

Authors:  Sona Nevsimalova
Journal:  Curr Neurol Neurosci Rep       Date:  2014-08       Impact factor: 5.081

5.  Presentations of primary hypersomnia in Chinese children.

Authors:  Fang Han; Ling Lin; Jing Li; Adi Aran; Song X Dong; Pei An; Long Zhao; Ming Li; Qian Y Li; Han Yan; Jie S Wang; Hui Y Gao; Mei Li; Zhan C Gao; Kingman P Strohl; Emmanuel Mignot
Journal:  Sleep       Date:  2011-05-01       Impact factor: 5.849

6.  Increased mortality in narcolepsy.

Authors:  Maurice M Ohayon; Jed Black; Chinglin Lai; Mark Eller; Diane Guinta; Arun Bhattacharyya
Journal:  Sleep       Date:  2014-03-01       Impact factor: 5.849

Review 7.  Clinical and neurobiological aspects of narcolepsy.

Authors:  Seiji Nishino
Journal:  Sleep Med       Date:  2007-04-30       Impact factor: 3.492

8.  CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice.

Authors:  Raphaël Bernard-Valnet; Lidia Yshii; Clémence Quériault; Xuan-Hung Nguyen; Sébastien Arthaud; Magda Rodrigues; Astrid Canivet; Anne-Laure Morel; Arthur Matthys; Jan Bauer; Béatrice Pignolet; Yves Dauvilliers; Christelle Peyron; Roland S Liblau
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-12       Impact factor: 11.205

Review 9.  Neuroimaging findings in narcolepsy with cataplexy.

Authors:  Thien Thanh Dang-Vu
Journal:  Curr Neurol Neurosci Rep       Date:  2013-05       Impact factor: 5.081

10.  Increased immune complexes of hypocretin autoantibodies in narcolepsy.

Authors:  Aude Deloumeau; Sophie Bayard; Quentin Coquerel; Pierre Déchelotte; Christine Bole-Feysot; Bertrand Carlander; Valérie Cochen De Cock; Sergueï O Fetissov; Yves Dauvilliers
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.